~~<i id='6A5B6AFFC0'><strike id='6A5B6AFFC0'><tt id='6A5B6AFFC0'><pre id='6A5B6AFFC0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：Wikipedia 2025-10-02 17:26:58 - browse：5

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.

About last night…

House leadership last night canceled a scheduled vote on a health care package that included transparency requirements for hospitals and insurers, reforms to some PBM practices, and a small site-neutral payment policy for administering drugs, Rachel writes.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The Biogen Aduhelm mess could happen again

explore

hotspot

focus

AdobeLately,we’veseentwodistinctlinesatourhospitals.Wewouldallbehealthierifwebroughtthetwolinestoget

WSS

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Senate panel clears PBM, hopsital reforms

HPV cancer vaccine study demonstrates efficacy

Top private equity targets in 2023: cardiology, clinical trials, lasers

What’s missing from the debate over nursing home staff minimums

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

fashion

explore

As demand for Covid shots wanes, Moderna seeks its next success

Excited delirium, Elijah McClain, and emergency physicians

Heart attack and stroke risk calculators need revising

Why CTE doesn’t keep Americans from enjoying the Super Bowl

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

The high cost of giving birth even with insurance

Readout LOUD: Venture capital, Gilead, and more M&A

In Memoriam: Notable people who died in 2023

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

explore

Why Novartis is going to walk from its acquisition of MorphoSys

Will General Catalyst be the first of many hospital takeovers?

AstraZeneca stays mum on Medicare drug pricing negotiations

Free speech concerns arise in wake of journal editor Eisen's firing

Problems with a popular proposal to regulate AI in health care

Removing probiotics from the NICU could threaten preemies' health

hotspot

hotspot

hotspot

focus